cGxP.wire https://validator.w3.org/feed/docs/rss2.html Takeda’s ENTYVIO Nears Pediatric IBD FDA Approval Philips Finds AI Boosting Patient Access and Clinical Efficiency Worldwide HERVolution Advances Immune Therapy for Metabolic Disease Smith+Nephew Launches Next-Generation CORI XT Robotics Novartis and Orionis Expand AI-Powered Molecular Glue Alliance Nasus Pharma Reports Positive Preclinical Results for NS003 Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval Teva Acquires Emalex to Advance Tourette Syndrome Therapy Disc Medicine Shares FDA Meeting Outcomes for Bitopertin Eli Lilly and Shaquille O’Neal Raise Awareness of Treatable Sleep Apnea with Zepbound Vara Secures CE Mark for 3D Mammography AI Platform Matica Biotechnology Partners with UHN on IL-10 Gene Therapy Manufacturing UCB Receives Favorable Canadian Reimbursement Opinion for BIMZELX Lilly’s EBGLYSS Wins FDA Approval for Reduced Injection Schedule Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor Kyowa Kirin Highlights Vision 2030 in Integrated Report Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment Onkos Surgical Receives FDA Nod for NanoCept-Enhanced Implants Alpha Cognition Reports Positive BEACON Study Results for ZUNVEYL Zetagen Therapeutics Reports Positive Phase 2a ZetaMet Results Multi Radiance Medical Expands FDA-Cleared Laser Therapy Indications Cellectis Secures FDA RMAT Status for Lasme-cel CONNECTA Therapeutics Initiates Phase IIa Study of CTH120 Antengene Secures China IND Clearance for ATG-201 Harbour BioMed Clears Regulatory Milestone for HBM7004 Sanofi Ends Phase 3 MOBILIZE Trial of Riliprubart in CIDP Argo Biopharma Reports Positive Phase 2 HAE Data for BW-20805 AlzeCure and Eli Lilly Partner on Alzheimer’s Drug ACD680 Kelun-Biotech and Windward Bio Advance SKB378 in COPD Vertanical’s Exilby Wins First European Approval for Chronic Pain RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status Bial Discontinues Pariceract After Phase 2b ACTIVATE Trial Miss Pentixapharm Advances PANDA Phase 3 Study After FDA Clearance Novanta Acquires Riverpoint Medical in $1.45 Billion Deal PureTech and Seaport Report Positive GlyphAgo Phase 1 Data Zai Lab Secures China Approval for TIVDAK in Cervical Cancer insitro Advances AI-Discovered CTRO-1013 for MASH With Anti-Fibrotic Data Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion Incyte to Acquire Vega Therapeutics for $2 Billion Deal Spruce Biosciences Reports Six-Year TA-ERT Data in MPS IIIB Thirdwayv Technology Powers FDA-Authorized Glas G2 Platform Neurocrine Biosciences Reports New INGREZZA Data in Tardive Dyskinesia DBV Technologies Reports Positive VITESSE Data for VIASKIN Peanut Patch FDA Approves New Sunscreen Ingredient After Two Decades Waters Launches New Platform for GLP-1 and LNP Analytics JCR Pharmaceuticals Presents New MPS Clinical Data at MPS 2026 Merck and Gilead End KEYNOTE-D46 Study Update IBA Receives FDA Approval for First ConformalFLASH Human Trial Oncolys BioPharma Secures Japan Approval for Telomelysin in Esophageal Cancer